You just read:

Adynxx Completes Enrollment in ADYX-004, a Phase 2 Study of Brivoligide (AYX1), Lead Compound for the Treatment of Post-Surgical Pain

News provided by

Adynxx

Oct 04, 2017, 08:00 ET